Research location
Oakland Park
Florida, United States
Advertisement
Research activity in Oakland Park
Florida, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 65 trials and 65 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Oakland Park
65 linked trials · page 2 of 2Long Term Safety Study of NVA237 vs QAB149 in COPD PatientsNCT01697696 · 2012-10-01 · 1 site observation
COMPLETED
Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus RilpivirineNCT01641809 · 2012-08-06 · 1 site observation
COMPLETED
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)NCT01601704 · 2012-06-01 · 1 site observation
TERMINATED
A Long-Term Safety Study of Pomaglumetad Methionil in SchizophreniaNCT01487083 · 2011-12-01 · 1 site observation
TERMINATED
Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)NCT01360866 · 2011-10-01 · 1 site observation
COMPLETED
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot AripiprazoleNCT01432444 · 2011-09-01 · 1 site observation
COMPLETED
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake InhibitorNCT01185340 · 2011-03-01 · 1 site observation
COMPLETED
Relapse Prevention Study in Patients With SchizophreniaNCT01291511 · 2011-02-01 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01313676 · 2011-01-25 · 1 site observation
COMPLETED
Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes MedicationsNCT01107886 · 2010-05-01 · 1 site observation
COMPLETED
A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected SubjectsNCT00363142 · 2006-05-01 · 1 site observation
COMPLETED
Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected SubjectsNCT00197145 · 2005-07-21 · 1 site observation
TERMINATED
Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140NCT00123890 · 2005-06-01 · 1 site observation
TERMINATED
QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) InfectionNCT00232908 · 2004-06-01 · 1 site observation
COMPLETED
Atazanavir for HIV Infected Individuals: An Early Access ProgramNCT00046345 · 2002-05-01 · 1 site observation
NO_LONGER_AVAILABLE
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.